![G. Kahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
G. Kahn
Director/Board Member at
SOLID BIOSCIENCES INC.
Net worth: 21 726 $ as of 31/05/2026
Profile
G.
Clare Kahn is currently President at Clare Kahn Pharma Consulting LLC since 2016.
Independent Director at Solid Biosciences, Inc. since 2021.
Independent Director at Stoke Therapeutics, Inc. starting in 2026.
Formerly Vice President-Global Innovative Pharma at Pfizer Inc. from 2014 to 2016.
Vice President-Regulatory Affairs at GSK Plc from 1999 to 2010.
Chief Regulatory & Preclinical Development Officer at X-Vax Technology, Inc. from 2018 to 2019.
Assistant Professor at the University of Pennsylvania from 1981 to 1985.
Earned a doctorate from Royal Postgraduate Medical School in 1981.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 10/06/2026 | 2,960 ( 0% ) | 21 726 $ | 31/05/2026 |
G. Kahn active positions
| Companies | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Board Member | 02/03/2021 |
| STOKE THERAPEUTICS, INC. | Director/Board Member | 03/04/2026 |
Clare Kahn Pharma Consulting LLC | President | 01/06/2016 |
Former positions of G. Kahn
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/06/2016 |
| GSK PLC | General Counsel | 01/01/2010 |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1985 |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Chief Tech/Sci/R&D Officer | - |
Training of G. Kahn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Royal Postgraduate Medical School
 Royal Postgraduate Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clare Kahn Pharma Consulting LLC |
- Stock Market
- Insiders
- G. Kahn
